Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 16, 2018. The document serves as a transaction notification regarding dealings in the company's ordinary shares by Persons Discharging Managerial Responsibilities (PDMRs) and persons closely associated with them.
Key Financial Metrics
The filing does not provide consolidated financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. It strictly reports on specific share transactions.
| Transaction Date | Instrument | Price per Share | Volume | Transaction Type |
|---|---|---|---|---|
| October 12, 2018 | Ordinary Shares (25p each) | £14.580 | 25 | Acquisition (Dividend Re-investment) |
| October 12, 2018 | Ordinary Shares (25p each) | £14.580 | 21 | Acquisition (Dividend Re-investment) |
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document details two separate acquisitions of ordinary shares by company insiders, executed on the London Stock Exchange. Both transactions were acquisitions resulting from the re-investment of dividends paid on October 11, 2018, on shares held within Individual Savings Accounts (ISAs).
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It is a regulatory disclosure of insider trading activity compliant with Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
Key Facts for Investor Verification
- Insiders Involved: Mr. D S Redfern (Chief Strategy Officer) and Mrs. V A Whyte (Company Secretary).
- Transaction Nature: Both transactions were automatic acquisitions via dividend re-investment plans within ISAs, not open market purchases.
- Market Price: The shares were acquired at £14.580 per share on October 12, 2018.
- Volume: Mr. Redfern acquired 25 shares; Mrs. Whyte acquired 21 shares.
- Reporting Limitation: This filing does not contain quarterly or annual financial performance data.